Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes.

Journal Article (Journal Article)

Full Text

Duke Authors

Cited Authors

  • Swords, RT; Watts, J; Erba, HP; Altman, JK; Maris, M; Anwer, F; Hua, Z; Stein, H; Faessel, H; Sedarati, F; Dezube, BJ; Giles, FJ; Medeiros, BC; DeAngelo, DJ

Published Date

  • February 3, 2017

Published In

Volume / Issue

  • 7 / 2

Start / End Page

  • e520 -

PubMed ID

  • 28157218

Pubmed Central ID

  • PMC5386335

Electronic International Standard Serial Number (EISSN)

  • 2044-5385

Digital Object Identifier (DOI)

  • 10.1038/bcj.2017.1


  • eng

Conference Location

  • United States